ATA950774A - Verfahren zur herstellung von neuen d-homo-20-ketopregnanen - Google Patents

Verfahren zur herstellung von neuen d-homo-20-ketopregnanen

Info

Publication number
ATA950774A
ATA950774A AT950774A AT950774A ATA950774A AT A950774 A ATA950774 A AT A950774A AT 950774 A AT950774 A AT 950774A AT 950774 A AT950774 A AT 950774A AT A950774 A ATA950774 A AT A950774A
Authority
AT
Austria
Prior art keywords
ketopregnanes
homo
manufacturing new
manufacturing
new
Prior art date
Application number
AT950774A
Other languages
English (en)
Other versions
AT347611B (de
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of ATA950774A publication Critical patent/ATA950774A/de
Application granted granted Critical
Publication of AT347611B publication Critical patent/AT347611B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
AT950774A 1973-11-30 1974-11-27 Verfahren zur herstellung von neuen d-homo-20- ketopregnanen AT347611B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (2)

Publication Number Publication Date
ATA950774A true ATA950774A (de) 1978-05-15
AT347611B AT347611B (de) 1979-01-10

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
AT950774A AT347611B (de) 1973-11-30 1974-11-27 Verfahren zur herstellung von neuen d-homo-20- ketopregnanen

Country Status (14)

Country Link
US (1) US4045574A (de)
JP (1) JPS5084561A (de)
AT (1) AT347611B (de)
CA (1) CA1030522A (de)
CH (1) CH618183A5 (de)
DD (1) DD115659A5 (de)
DK (1) DK134348C (de)
ES (1) ES432106A1 (de)
FR (1) FR2253512B1 (de)
GB (1) GB1494097A (de)
IE (1) IE40423B1 (de)
IL (1) IL46153A (de)
NL (1) NL7415577A (de)
SE (1) SE408426B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
AU2003285485A1 (en) * 2002-08-16 2004-03-03 Pharmacia & Upjohn Company Llc 5 ANDROSTEN-3Beta-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
LT2986624T (lt) 2013-04-17 2020-07-10 Sage Therapeutics, Inc. Neuroaktyvūs 9-nor steroidai, skirti gydymo metodams
LT2986623T (lt) 2013-04-17 2019-02-25 Sage Therapeutics, Inc. 19-nor c3,3-dipakeistieji c21-n-pirazolilo steroidai ir jų panaudojimo būdai
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
RS61733B1 (sr) 2013-07-19 2021-05-31 Sage Therapeutics Inc Neuroaktivni steroidi, njihove kompozicije i upotrebe
BR112016003862B1 (pt) 2013-08-23 2022-09-06 Sage Therapeutics, Inc Compostos esteroides neuroativos, suas composições e seus usos
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AU2015331749A1 (en) 2014-10-16 2017-05-04 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
EP3753927B1 (de) 2014-10-16 2023-07-19 Sage Therapeutics, Inc. Zusammensetzungen und verfahren zur behandlung von störungen des zentralen nervensystems
HRP20200840T1 (hr) 2014-11-27 2020-11-13 Sage Therapeutics, Inc. Pripravci i postupci za liječenje poremećaja cns-a
LT3250210T (lt) 2015-01-26 2021-04-12 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti gydyti cns sutrikimus
DK3258939T3 (da) 2015-02-20 2022-12-12 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser heraf
WO2018013615A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
AU2017297375B2 (en) 2016-07-11 2022-09-15 Sage Therapeutics, Inc. C17, C20, and C21 substituted neuroactive steroids and their methods of use
WO2019126761A1 (en) * 2017-12-22 2019-06-27 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP3902818A1 (de) 2018-12-05 2021-11-03 Sage Therapeutics, Inc. Neuroaktive steroide und ihre verfahren zur verwendung
JP7592600B2 (ja) 2019-01-08 2024-12-02 成都康弘薬業集団股▲フン▼有限公司 ステロイド化合物、その使用、およびその調製方法
WO2020243488A1 (en) 2019-05-31 2020-12-03 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof
WO2020264495A1 (en) * 2019-06-27 2020-12-30 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
AU2020302748A1 (en) 2019-06-27 2022-01-06 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
EP3990468A1 (de) * 2019-06-27 2022-05-04 Sage Therapeutics, Inc. Verbindungen zur behandlung von erkrankungen des zns

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
IL46153A (en) 1979-01-31
US4045574A (en) 1977-08-30
CA1030522A (en) 1978-05-02
IL46153A0 (en) 1975-02-10
SE7414960L (de) 1975-06-02
FR2253512A1 (de) 1975-07-04
ES432106A1 (es) 1976-11-01
IE40423L (en) 1975-05-30
GB1494097A (en) 1977-12-07
DK134348B (da) 1976-10-25
SE408426B (sv) 1979-06-11
DD115659A5 (de) 1975-10-12
JPS5084561A (de) 1975-07-08
DK134348C (da) 1977-03-21
IE40423B1 (en) 1979-05-23
NL7415577A (nl) 1975-06-03
AU7586774A (en) 1976-06-03
CH618183A5 (de) 1980-07-15
AT347611B (de) 1979-01-10
DK604174A (de) 1975-07-28
FR2253512B1 (de) 1978-02-03

Similar Documents

Publication Publication Date Title
AT341119B (de) Verfahren zur herstellung von neuen prostanderivaten
AT347611B (de) Verfahren zur herstellung von neuen d-homo-20- ketopregnanen
AT327181B (de) Verfahren zur herstellung von neuen phenylindanestern
AT336555B (de) Verfahren zur herstellung von neuen athoxylierten hydroxyathern
AT341689B (de) Verfahren zur herstellung von neuen octapeptiden
AT351180B (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT333300B (de) Verfahren zur herstellung von neuen hydroxyalkylxanthinen
AT340612B (de) Verfahren zur herstellung von neuen 25-hydroxycholesterinen
AT339913B (de) Verfahren zur herstellung von neuen diazin-derivaten
AT335456B (de) Verfahren zur herstellung von cyanpyridinen
AT330957B (de) Verfahren zur herstellung von neuen penicillinen
AT332972B (de) Verfahren zur herstellung von neuen penicillinen
AT326821B (de) Verfahren zur herstellung von neuen penicillinen
ATA562274A (de) Verfahren zur herstellung von neuen bis-triazinobenzimidazolen
AT334879B (de) Verfahren zur herstellung von neuen arylathern
AT327385B (de) Verfahren zur herstellung von neuen penicillinen
AT329183B (de) Verfahren zur herstellung von neuen penicillinen
AT333958B (de) Verfahren zur herstellung von neuen cephalosporinantibiotica
ATA543975A (de) Verfahren zur herstellung von neuen hydroxyalkylxanthinen
ATA904574A (de) Verfahren zur herstellung von neuen hydroxyalkylxanthinen
ATA904674A (de) Verfahren zur herstellung von neuen hydroxyalkylxanthinen
AT338229B (de) Verfahren zur herstellung von neuen aldehydolactonen
AT339880B (de) Verfahren zur herstellung von neuen bicycloalkanderivaten
ATA243775A (de) Verfahren zur herstellung von neuen 1-acyl-3- biphenylyl-propanonen
ATA896174A (de) Verfahren zur herstellung von neuen triazinobenzimidazolen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee